Daniel Tassé
Chief Executive Officer bei DBV TECHNOLOGIES
Vermögen: 87 993 $ am 31.03.2024
Profil
Daniel Tassé is currently the Chief Executive Officer & Executive Director at DBV Technologies SA. He is also a Director at BioQ Pharma, Inc., an Independent Non-Executive Director at REGENXBIO, Inc., and a Director at Roundtable On Critical Care Policy.
Previously, Mr. Tassé held several positions including Chairman, President & Chief Executive Officer at Ikaria, Inc., Chairman & Chief Executive Officer at Alcresta Therapeutics, Inc., Director at Biotechnology Innovation Organization, Director at Bellerophon Therapeutics, Inc., Senior Independent Director at Indivior PLC, Vice President & Regional Director-Australasia at GSK Plc, Director at Pharmaceutical Research & Manufacturers of America, Independent Director at HLS Therapeutics, Inc., and GM-Pharmaceuticals & Technologies Business Unit at Baxter International, Inc. He was also a Member of the Healthcare Leadership Council and Chief Financial Officer at NRG Energy Ltd.Mr. Tassé completed his undergraduate degree at the University of Montréal.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REGENXBIO, INC.
0,01% | 01.04.2024 | 3 010 ( 0,01% ) | 63 421 $ | 31.03.2024 |
DBV TECHNOLOGIES SA
0,02% | 08.03.2024 | 17 094 ( 0,02% ) | 24 572 $ | 31.03.2024 |
Aktive Positionen von Daniel Tassé
| Unternehmen | Position | Beginn |
|---|---|---|
| REGENXBIO INC. | Director/Board Member | 15.08.2016 |
| DBV TECHNOLOGIES | Chief Executive Officer | 29.11.2018 |
BioQ Pharma, Inc.
 BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | Director/Board Member | 01.12.2014 |
| Roundtable On Critical Care Policy | Director/Board Member | - |
Ehemalige bekannte Positionen von Daniel Tassé
| Unternehmen | Position | Ende |
|---|---|---|
| INDIVIOR PLC | Chairman | 19.11.2020 |
| BELLEROPHON THERAPEUTICS, INC. | Chief Executive Officer | 01.06.2014 |
| HLS THERAPEUTICS INC. | Director/Board Member | 01.03.2019 |
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Chief Executive Officer | 01.11.2018 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 01.06.2015 |
Ausbildung von Daniel Tassé
| University of Montréal | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 7 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| REGENXBIO INC. | Health Technology |
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| INDIVIOR PLC | Health Technology |
| GSK PLC | Health Technology |
| DBV TECHNOLOGIES | Health Technology |
| HLS THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
Healthcare Leadership Council
 Healthcare Leadership Council Medical/Nursing ServicesHealth Services Healthcare Leadership Council operates as a organization focusing on the provision of a healthcare system. The company is headquartered in Washington, DC. | Health Services |
| NRG Energy Ltd. | |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Health Technology |
| Roundtable On Critical Care Policy |
